Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17

Aflibercept is an inhibitor of vascular endothelial growth factor (VEGF) used to treat macular edema following branch retinal vein occlusion (BRVO). Despite well-documented efficacy, there is limited knowledge about proteome changes following aflibercept intervention in BRVO. Proteome changes may pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cehofski, Lasse Jørgensen, Kruse, Anders, Alsing, Alexander Nørgård, Sejergaard, Benn Falch, Nielsen, Jonas Ellegaard, Pedersen, Shona, Muttuvelu, Danson Vasanthan, Kirkeby, Svend, Honoré, Bent, Vorum, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960061/
https://www.ncbi.nlm.nih.gov/pubmed/33747556
http://dx.doi.org/10.1155/2021/6690260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960061/
https://www.ncbi.nlm.nih.gov/pubmed/33747556
http://dx.doi.org/10.1155/2021/6690260

Ejemplares similares